Electroporation-based DNA immunisation: translation to the clinic. - Wikidata - awgldk - TriplyDB

Electroporation-based DNA immunisation: translation to the clinic.

Electroporation-based DNA immunisation: translation to the clinic.

http://www.wikidata.org/entity/Q36981658

about

Biodegradable nanoneedles for localized delivery of nanoparticles in vivo: exploring the biointerface Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses.Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.Vaccine design for CD8 T lymphocyte responses Microscale electroporation: challenges and perspectives for clinical applications.Gene therapy by electroporation for the treatment of chronic renal failure in companion animals Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments Tolerability of two sequential electroporation treatments using MedPulser DNA delivery system (DDS) in healthy adults.Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.Spontaneous and Vaccine-Induced Clearance of Mus Musculus Papillomavirus 1 Infection Therapeutic HPV DNA vaccines.Influenza virus vaccine based on the conserved hemagglutinin stalk domain.Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients.DNA vaccines for biodefense.Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks.Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor.A pan-H1 anti-hemagglutinin monoclonal antibody with potent broad-spectrum efficacy in vivo Targeted Collection of Plasmid DNA in Large and Growing Animal Muscles 6 Weeks after DNA Vaccination with and without Electroporation.Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus.Harnessing DNA-induced immune responses for improving cancer vaccines.DNA vaccines targeting human papillomavirus-associated diseases: progresses in animal and clinical studies.Chimeric DNA Vaccines against ErbB2+ Carcinomas: From Mice to Humans.Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine.Antibodies designed as effective cancer vaccines.Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.Electrodes for in vivo localised subcutaneous electropulsation and associated drug and nucleic acid delivery.Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.Electroporation for DNA immunization: clinical application.Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation.Novel Cross-Reactive Monoclonal Antibodies against Ebolavirus Glycoproteins Show Protection in a Murine Challenge Model.

P2860

Q27342204-9E5DCA60-4CA0-4AB3-AC50-74B5EF61BCCC Q30227194-18F99182-DD13-4F3E-AF29-90647B03B471 Q30228657-B2994705-9E7D-40C8-9005-014F5C0C9E94 Q30382097-BD9D2EFA-6F24-42F9-9DD9-15AD740CA86F Q30400895-BBF23FBC-DB6A-4607-9BE4-5D43585728D9 Q30411492-62A8FA4C-4343-4EE8-846D-723AF8FF2B8A Q30449429-0313898B-0492-4B89-A5DE-866F243C9D01 Q33400571-ACD4E915-E00F-4641-9180-0904994EA162 Q33507532-2EE70419-76C3-44E1-B26C-BA6ED2224AFF Q33527383-C82777B4-1FC6-4B46-BABA-BFC1096019A7 Q33586294-2DFA14F3-ED40-463D-B6B9-0DCE6C40AA6B Q33713435-18D2CEA0-EB34-4F32-A921-79BCC76AE1D7 Q33713542-A09DF9E1-8B43-4458-A841-C655CE9E7528 Q33778143-184E4147-72F8-4B93-B961-3AC569B60646 Q33907700-E943838E-FE9A-476E-9605-D22DF5B4AEA4 Q33936427-70A978CB-33DE-40FB-93D4-CCD13CB39950 Q34030587-D86C6062-CD6E-4D22-B3B5-52E85C8524CA Q34298878-FD82A6C2-D8D0-4178-9FF6-E4521E38E67C Q34453827-C56509E5-96B3-4563-B95B-2588B61DA9B3 Q34614260-3B9E67AE-B703-4208-BCC9-4163BE6584C5 Q34621352-76646366-A118-4A60-BCAC-86070C18FF1A Q34621661-0E9EA7EF-7481-4473-8BCF-812171681E07 Q35076712-01D912B6-948A-47EE-96B5-D0D5CFDC628B Q35156471-CE781CD1-08DB-4E18-9D63-8DB9FEB29312 Q35646675-15BEDC29-0260-4223-A561-495AC91B9507 Q35890518-6658F875-2878-4D24-B976-AA6F02D222F8 Q36023093-F4C141E6-CDD1-4CA2-ADDB-185EE17247E4 Q36034319-2AE08B22-03B0-4E24-8578-6C6C284941D9 Q36694825-0BC8689A-C29D-49B8-9EEE-7AB9CFC1ED99 Q36694866-556EE324-6354-4B65-9B0A-2EC4DA953FD1 Q37010987-C5CD7452-7ED9-4A86-AA1B-D3783E05F674 Q37137404-EEB8C5BD-0383-484E-A1A6-86FC1AC2C03F Q37259608-D41D3FC0-D5BB-45AE-A623-6E827E57C983 Q37273469-379FDB67-1140-4D86-85FB-717F26420D01 Q37351412-AEBD9277-2858-4877-9B01-BA2C2DBCA9BA Q37622247-6E310B4F-FF32-42B8-93F1-5B9D4D12809E Q37634138-ECAF369B-CC52-4FAB-B5D5-100D4793552C Q37744992-BC240156-E643-42D1-A5AB-1BD9BD7654A0 Q38610641-6C4DA092-8509-476E-9168-3BC2F165EED0 Q38673543-01647720-5F4D-4B41-AE06-27320DA5CEFD

P2860

Electroporation-based DNA immunisation: translation to the clinic.

http://www.wikidata.org/entity/Q36981658

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Electroporation-based DNA immunisation: translation to the clinic.

@en

type

label

Electroporation-based DNA immunisation: translation to the clinic.

@en

prefLabel

Electroporation-based DNA immunisation: translation to the clinic.

@en

P1433

Q36981658-0CA37761-D0AD-4955-916A-21502844D70C

P1476

Q36981658-851DD351-067D-4AF6-ADB9-DB597B9F6BD2

P2093

Q36981658-1ABD5106-A265-4317-B552-AFEC58E12458

Q36981658-A74A9B65-205B-4FA5-AC88-A8A938CCB4A2

Q36981658-CAE59C49-FD64-45DD-A2AF-DF7DED008264

P2860

Q36981658-00762BCF-68F4-4ECE-9F8F-523C98C2DEA1

Q36981658-00F4EB12-77D9-4E79-9F71-9EEFB45C1C8D

Q36981658-062D61E5-DBF5-48B5-BEF6-95D2F5BB3968

Q36981658-087A0A6A-27E4-4D31-8F9B-0D6D623C6C60

Q36981658-0B3102B3-EF4D-4BB1-B29F-5758BF0BCBE5

Q36981658-0E6EFB4F-3CAC-49F1-9B35-E3944B41BF08

Q36981658-0F9CB1C8-9141-4B35-BA6F-7325F06D4A49

Q36981658-0FC53F7D-2085-4616-AFA4-4E00ECFC7338

Q36981658-10D7A1A9-5835-4C0E-A8E3-DA9D0786B6B3

Q36981658-13BC5252-73D9-42DC-993C-7283C445CB50

P304

Q36981658-7D2EFE00-DD21-452F-AD38-6B97993914F7

P31

Q36981658-79AF7B3D-B4D6-4119-962F-B587B350FB9A

P356

Q36981658-13FB063E-FC8C-454B-BCD3-3749659CB94E

P407

Q36981658-9C69E0DF-674E-4838-B7C3-8CC2C6B80517

P433

Q36981658-F675250D-1764-44CC-A8B4-9357FE31E5D5

P478

Q36981658-C6CDEF87-E798-4B53-AE10-C41773D63639

P577

Q36981658-329CECE6-C470-4F9D-9103-6F1572DF59B0

P698

Q36981658-5FD43F7B-9C38-4F64-B06A-6ECD8366A45F

P921

Q36981658-04F32082-A5B1-4231-82E2-04F0744F132A

P356

14712598.7.11.1647

P1433

Expert Opinion on Biological Therapy

P1476

Electroporation-based DNA immunisation: translation to the clinic.

@en

P2093

Alain Luxembourg

http://www.w3.org/2001/XMLSchema#string

Claire F Evans

http://www.w3.org/2001/XMLSchema#string

Drew Hannaman

http://www.w3.org/2001/XMLSchema#string

P2860

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

Biodistribution of DNA Plasmid Vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile Virus Is Similar, without Integration, despite Differing Plasmid Backbones or Gene Inserts

DNA vaccines: immunology, application, and optimization*

Electroporation of cell membranes.

In vivo assessment of skin electroporation using square wave pulses.

Fundamentals of electroporative delivery of drugs and genes.

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein.

P304

1647-1664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.7.11.1647

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17961089

http://www.w3.org/2001/XMLSchema#string

P921

electroporation